Faculty Opinions recommendation of Canadian provider perspectives on Collagenase Clostridium histolyticum for the treatment of Peyronie's disease and the impact of its discontinuation.

Author(s):  
Matthew Ziegelmann
Sign in / Sign up

Export Citation Format

Share Document